Page 1256 - Small Animal Clinical Nutrition 5th Edition
P. 1256

1308 SMALL ANIMAL CLINICAL NUTRITION


                    in dogs and cats, 982                             Neuter
                    in rabbits, 1219f, 1223                             effect on energy requirement, 15b, 61t, 64-65, 258
                    in rodents, 1226, 1228                              relationship to obesity, 258, 258f, 374t, 375, 511-512
        VetBooks.ir  Manganese, 108t, 120                             NFE (See Nitrogen-free extract)
                  Materia alba, 983-984
                                                                      Niacin, function, metabolism and sources, 133-134
                  MCT (See Medium-chain triglycerides)                  canine blood levels, 132t
                  Meal-restricted feeding (See also Food-restricted meal feed-  feline blood levels, 132t
                    ing), 268t, 270t, 279t, 683-684                     requirements/deficiencies/excesses, 124t
                  Meat and bone meal, 89t, 94t, 174t, 210b            Nitrogen balance, 86, 92, 263, 276, 445, 483, 588, 782, 787b,
                  Meat byproducts, 197                                  1150, 1171, 1180
                  Medium-chain triglycerides, 97b, 338-339, 465-467, 470t,  Nitrogen-free extract (NFE) (See also Carbohydrates), 49, 51f
                    482b, 1079, 1080b, 1081t, 1137, 1170, 1291a       Non-insulin-dependent diabetes mellitus (NIDDM), feeding
                  Megacolon, in cats (See                               plan for, 567-570
                    Constipation/Obstipation/Megacolon)               Nucleotides, use in hospitalized patients, 456
                  Megaesophagus (See Pharyngeal and esophageal disorders)  Nutrient-drug interactions
                  Melamine toxicosis, 247-249c                          ACE inhibitors and potassium, 753-754
                  Metabolic acidosis, in chronic kidney disease, 774t, 779, 780t,  cardiac glycosides and electrolytes, 754-755
                    783b, 787b, 793-794                                 diuretics and magnesium, 751-753
                  Metabolic bone disease (See Hyperparathyroidism)      diuretics and potassium, 751-753
                  Metabolic yield (exercise), 329b                    Nutrients
                  Metabolizable energy (ME), 53-66, 55f                 conditionally essential, 68, 80b, 82, 83t, 84t, 93, 94, 123
                  Metallothionein, 109, 118-119, 645, 680, 1174, 1174f, 1190-  definition of, 49
                    1192c                                               drug interactions with, 1205-1207, 1205t
                  Methionine, 84t, 86, 89t, 90t, 92, 94t, 123, 124t, 138, 154,  of concern (as part of key nutritional factors), 8
                    367, 367t, 371-372b, 598, 648, 1164b, 1181b, 1222t, 1227t,  Nutrigenomics, 43-48
                    1260t                                               glossary, 44t
                  Microminerals, 107, 117-122                           canine and feline genomes, 47-48, 47b, 48b
                  Micronutrients: Minerals and vitamins, 107-148      Nutrition of reptiles, 1237-1254
                  Milk
                    nutritional composition, canine, 283t, 307t, 419t  O
                    nutritional composition, feline, 283t, 419t       Oats, 71, 72, 81, 86, 172
                  Milk replacers                                      Obesity, 499-542
                    nutritional composition, canine, 306t               assessment techniques for, 503-520, 504b
                    nutritional composition, feline, 424t                 body condition score, 504-507, 506t, 508b, 527b, 528t,
                  Minerals                                                531b
                    affects of fiber on, 79, 79t, 81, 514                 morphometric measurements, 507, 536-537c, 537-538c,
                    availability of, 111-112                              539-540c
                    definition of, 107                                    relative body weight, 501
                    functions of, 107-109,108t                          cardiovascular consequences of, 502, 734-735
                    interactions of, 110-111, 109f                      clinical importance of, 501-503
                    skin and hair disorders, 641, 645f, 645-648, 646t   commercial foods for management of, 524t, 525t, 526t,
                  Moist pet food, (See also Canned [moist] pet food), 158-159,  533t, 534t
                    184-188, 185f, 186f, 187f                           diseases associated with, 502t
                  Moisture content, of pet food, 11b, 158-159, 169, 195, 198  drugs for, 533b
                  Morphometric measurements, in obesity, 507, 536-537c, 537-  effects on drug metabolism, 1207
                    538c, 539-540c                                      exercise for management of, 510b, 511, 521b
                  Muscle (See Skeletal muscle)                          feeding plans for patients with, 519-534
                  Musculoskeletal disorders (See Developmental orthopedic  calculated time for weight loss, 532b
                    disease, Osteoarthritis)                              food dose calculation
                  Mycotoxins, in food, 230t, 233-234, 241c, 245-246c, 269b,  for weight loss, 528t, 529f
                                                                           for weight maintenance, 530f, 535t
                  N                                                       prevention of weight gain, 530-535, 535t
                  N-3 fatty acids (See Fatty acids)                     health risks of, 501-503, 502t
                  N-6 fatty acids (See Fatty acids)                     key nutritional factors for patients with, 512-519, 512t
                  Nasoesophageal feeding tubes, 458-459, 460-461b       monitoring response to treatment, 531b
                  National Research Council (NRC), 8, 192-193, 192t     predisposed breeds, 510
                  Neoplasia (See Cancer)                                prevalence in cats, 501
                  Nephrocalcin, 817, 818, 860-861, 872, 942             prevalence in dogs, 501
                  Nephrocalcinosis, 777f, 788, 878t                     regulatory definitions of, 513b
                  Nephrolithiasis, 819, 874-875                         relationship to diabetes mellitus in cats, 560t, 562-563
                  Nephroliths, mineral composition of, 829t             relationship to gender, age and gonadectomy, 511
                  Nephrotoxicity, drugs that cause, 768, 1027, 1202     risk factors for, 509-512
   1251   1252   1253   1254   1255   1256   1257   1258   1259   1260   1261